Genetic variations in the androgen receptor gene and finasteride response in women with androgenetic alopecia mediated by epigenetics

Dermatologic Therapy

Volumn 24, Issue 2, 2011, Pages 296-300

  Keene, Sharon ^a   Goren, Andy ^a  

^a DermaGenoma Inc   (United States)

Author keywords

AR gene; CAG AGA; Female FPHL alopecia

Indexed keywords

ANDROGEN RECEPTOR; FINASTERIDE; PLACEBO; AR PROTEIN, HUMAN; STEROID 5ALPHA REDUCTASE INHIBITOR;

ALLELE; ALOPECIA; ARTICLE; CLINICAL ARTICLE; EPIGENETICS; EXON; FEMALE; GENETIC VARIABILITY; HAIR LOSS; HUMAN; NUCLEOTIDE SEQUENCE; POSTMENOPAUSE; TREATMENT RESPONSE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; PHENOTYPE; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME; TRINUCLEOTIDE REPEAT;

5-ALPHA REDUCTASE INHIBITORS; ALOPECIA; EPIGENESIS, GENETIC; FEMALE; FINASTERIDE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; PHENOTYPE; PILOT PROJECTS; RECEPTORS, ANDROGEN; TIME FACTORS; TREATMENT OUTCOME; TRINUCLEOTIDE REPEATS;

EID: 79952762129     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2011.01407.x     Document Type: Article

References (18)

1. Price V, Roberts J, Hordidnsky M, et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol 2000: 43: 768-776.
2. Whiting D, Waldstreicher J, Sanchez M, Kaufman K. Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women. J Investig Dermatol Symp Proc 1999: 4 (3): 282-284. (Pubitemid 30085821)
3. Trueb R. Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women. Dermatology 2004: 209 (3): 202-207. (Pubitemid 39370328)
4. Iorizzo M, Vincenzi C, Voudouris S, Piraccine B, Tosti A. Finasteride treatment of female pattern hairloss. Arch Dermatol 2006: 142 (3): 298-302.
5. Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hairloss with oral anti-androgens. Br J Dermatol 2005: 152 (3): 466-473. (Pubitemid 40547120)
6. Alsantali A, Shapiro J. Androgens and hair loss. Curr Opin Endocrinol Diabetes Obes 2009: 16 (3): 246-253.
7. Ellis J, Stebbing M, Harrup S. Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Invest Dermatol 2001: 116: 452-455. (Pubitemid 32202911)
8. Hillmer A, Hanneken S, Ritzmann S, et al. Genetic variation in the human androgen gene is the major determinant of common early onset androgenetic alopecia. Am J Hum Genet 2005: 77: 140-148. (Pubitemid 40848045)
9. Levy-Nissenbaum E, Bar-Natan M, Frydman M, Pras E. Conformation of the association between male pattern baldness and the androgen receptor gene. Eur J Dermatol 2005: 15 (5): 339-340. (Pubitemid 41337408)
10. Hayes V, Severi G, Eggleton S, et al. The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia. Cancer Epidemiol Biomarkers Prev 2005: 14 (4): 993-996. (Pubitemid 40478569)
11. Sinclair R, Greenland KJ, van Egmond S, Hoedemaker C, Chapman A, Zajac JD. Men with Kennedy disease have a reduced risk of androgenetic alopecia. Br J Dermatol 2007: 157: 290-294. (Pubitemid 47083864)
12. SawayaM, Shalita A. Androgen receptor polymorphisms in androgenetic alopecia, hirsutism, and acne. J Cutan Med Surg 1998: 3 (1): 9-15.
13. Vottero A, Stratakis C, Ghizzoni L, Longui C, Karl M, Chrousos G. Androgen receptor mediated hypersensitivity to androgens in women with nonhyperandrogenic hirsutism: skewing of the X chromosome inactivation. J Clin Endocrinol Metab 1999: 84 (3): 1091-1095. (Pubitemid 29138248)
14. Ong K, Zegher F, Lopez-Bernejo A, Dunger D, Ibanez L. Flutamide-metformin for post menarcheal girls with preclinical ovarian androgen excess: evidence for differential response by androgen receptor genotype. Eur J Endocrinol 2007: 157: 661-668. (Pubitemid 350187384)
15. Mohlig M, Jurgens A, Spranger J, et al. The androgen receptor CAG repeat modifies the impact of Testosterone on insulin resistance in women with polycystic ovary syndrome. Eur J Endocrinol 2006: 155 (1): 127-130. (Pubitemid 44103380)
16. Waikisaka N, Taira Y, Ishikawara M, et al. Effectiveness of finasteride on patients with male pattern baldness who have different androgen receptor gene polymorphism. J Investig Dermatol Symp Proc 2005: 10: 293-294.
17. Sato A, Arima Y, Kojima Y, et al. Correlation between polymorphic CAG-repeats in the androgen receptor gene and therapeutic efficiency of finasteride in androgenetic alopecia. Skin Surg 2008: 17 (2): 84-86.
18. Nelson KA, Witte JS. Androgen receptor CAG repeats and prostate cancer. Am J Epidemiol 2008: 155 (10): 883-890.